We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
Cap. Flow
-$8.36M
Cap. Flow %
-0.43%
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$20.5M
2
CELH icon
Celsius Holdings
CELH
+$20M
3
AHCO icon
AdaptHealth
AHCO
+$19.3M
4
NOG icon
Northern Oil and Gas
NOG
+$18.9M
5
PRVA icon
Privia Health
PRVA
+$16.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$24.9M
2
AVNT icon
Avient
AVNT
+$21.7M
3
ONTO icon
Onto Innovation
ONTO
+$20M
4
ALKS icon
Alkermes
ALKS
+$19.3M
5
VC icon
Visteon
VC
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.67%
2 Industrials 16.05%
3 Consumer Discretionary 13.81%
4 Technology 13.49%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEFT icon
151
Euronet Worldwide
EEFT
$3.1B
$717K 0.04%
9,467
-76
-0.8% -$7.13K
TRMB icon
152
Trimble
TRMB
$12.4B
$710K 0.04%
13,077
-107
-0.8% -$6.77K
MTZ icon
153
MasTec
MTZ
$26.6B
$698K 0.04%
10,992
-87
-0.8% -$6.73K
EFSC icon
154
Enterprise Financial Services Corp
EFSC
$2.45B
$695K 0.04%
15,785
– –
SMG icon
155
ScottsMiracle-Gro
SMG
$4.03B
$691K 0.04%
16,160
+6,332
+64% +$455K
TER icon
156
Teradyne
TER
$52.2B
$676K 0.03%
9,000
-5,986
-40% -$546K
SBNY
157
DELISTED
Signature Bank
SBNY
$648K 0.03%
4,291
+479
+13% +$87.1K
MP icon
158
MP Materials
MP
$8.14B
$637K 0.03%
23,344
-10,101
-30% -$330K
TREX icon
159
Trex
TREX
$4.49B
$632K 0.03%
14,390
-87,173
-86% -$4.66M
SPGI icon
160
S&P Global
SPGI
$133B
$610K 0.03%
1,998
-8
-0.4% -$2.86K
KEYS icon
161
Keysight
KEYS
$53.7B
$592K 0.03%
3,762
-29
-0.8% -$4.64K
POOL icon
162
Pool Corp
POOL
$7.33B
$564K 0.03%
1,772
+308
+21% +$110K
RMD icon
163
ResMed
RMD
$28.8B
$558K 0.03%
+2,555
New +$582K
OCFC icon
164
OceanFirst Financial
OCFC
$1.72B
$549K 0.03%
29,467
– –
SGEN
165
DELISTED
Seagen Inc. Common Stock
SGEN
$549K 0.03%
+4,009
New +$653K
SEAT icon
166
Vivid Seats
SEAT
$77.7M
$546K 0.03%
3,565
-42,351
-92% -$7.1M
ALNY icon
167
Alnylam Pharmaceuticals
ALNY
$36.4B
$520K 0.03%
2,600
-21
-0.8% -$4K
BC icon
168
Brunswick
BC
$5.14B
$520K 0.03%
7,940
-66
-0.8% -$4.95K
LHX icon
169
L3Harris
LHX
$52.3B
$496K 0.03%
2,388
-18
-0.7% -$4.15K
MCB icon
170
Metropolitan Bank Holding Corp
MCB
$1.22B
$493K 0.03%
7,661
-2,200
-22% -$156K
HAL icon
171
Halliburton
HAL
$29.3B
$492K 0.03%
19,968
-165
-0.8% -$4.72K
PDCE
172
DELISTED
PDC Energy, Inc.
PDCE
$492K 0.03%
8,511
+1,740
+26% +$107K
STE icon
173
Steris
STE
$20.9B
$485K 0.03%
2,914
-22
-0.7% -$4.48K
STVN icon
174
Stevanato
STVN
$5.23B
$472K 0.02%
27,845
-232
-0.8% -$3.9K
HES
175
DELISTED
Hess
HES
$466K 0.02%
4,272
-33
-0.8% -$3.66K
5 6
7
8 9

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
  • Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
  • Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
  • Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
  • Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
  • Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
  • Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.